The Application of mRNA Immunotherapy Technology in Refractory Malignancies Associated With Epstein-Barr Virus (EBV)

NCT07101536 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

EBV-associated Tumors

Interventions

BIOLOGICAL: EBV mRNA vaccine
BIOLOGICAL: Immune Checkpoint Inhibitors, ICIs

Sponsor

West China Hospital